[Neurological complications during therapy with 17 MDCAA (author's transl)].
A case of a 39 years old woman on therapy with Monodicloroacetilajmaline for repetitive crises of Ventricular Tachycardia is shown. We have observed neurological symptoms by central compromission of 3rd, 4th, 6th pair of cranial nerves, cutaneous symptoms and a neurodisletic crisis. We particularly analyse the dosage of the drug in relation to the progression of symptoms and also the possible pathogenesis. Symptoms disappeared completely about 20 days after withdrawal of the drug.
D000328:Adult; D000404:Ajmaline / Q000009:adverse effects* / Q000031:analogs & derivatives / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009422:Nervous System Diseases / Q000139:chemically induced*; D013610:Tachycardia / Q000188:drug therapy
D000404:Ajmaline
Complicanze neurologiche in corso di terapia con 17-MDCAA